Published in Blood on August 06, 2009
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev (2011) 5.51
Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor. Circ Cardiovasc Genet (2017) 0.75
[Perioperative prevention of thrombosis: routine and special risk groups]. Wien Med Wochenschr (2009) 0.75
New anticoagulants: perioperative considerations. Wien Med Wochenschr (2011) 0.75
[Perioperative thromboprophylaxis in adults]. Wien Med Wochenschr (2009) 0.75
Valves of the deep venous system: an overlooked risk factor. Blood (2009) 1.99
Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64
The risk of recurrent venous thromboembolism in men and women. N Engl J Med (2004) 7.41
Deep vein thrombosis. Lancet (2005) 3.43
Risk assessment for recurrent venous thrombosis. Lancet (2010) 3.31
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost (2007) 2.56
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med (2010) 1.83
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA (2006) 1.72
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]. Wien Klin Wochenschr (2007) 1.51
Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost (2006) 1.49
Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis (2012) 1.49
New diagnostic strategies for pulmonary embolism. Lancet (2008) 1.46
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology (2010) 1.23
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism. Thromb Haemost (2005) 1.06
Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost (2007) 1.04
Family history for venous thromboembolism and the risk for recurrence. Am J Med (2006) 0.93
Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism. Arch Intern Med (2006) 0.90
Low vitamin B6 levels and the risk of recurrent venous thromboembolism. Haematologica (2007) 0.89
Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism. J Vasc Surg (2008) 0.88
Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin. Thromb Haemost (2004) 0.85
Novel anticoagulants for the prevention and treatment of venous thromboembolism. Wien Med Wochenschr (2003) 0.85
Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin. Eur Heart J (2009) 0.83
Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. Medicine (Baltimore) (2009) 0.82
The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism. Wien Klin Wochenschr (2003) 0.81
Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences. J Clin Epidemiol (2013) 0.80
Clinical scores to predict recurrence risk of venous thromboembolism. Thromb Haemost (2012) 0.79
The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial. Thromb Haemost (2010) 0.79
ProCGlobal and endogenous thrombin potential during pregnancy. Am J Obstet Gynecol (2010) 0.79
Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study. PLoS One (2012) 0.79
Vitamin K antagonists: self-determination by self-monitoring? Lancet (2011) 0.78
Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg (2003) 0.77
The emotional impact of genetic testing and aspects of counseling prior to prescription of oral contraceptives. Contraception (2008) 0.77
Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study. PLoS One (2012) 0.76
Dabigatran: patient management in specific clinical settings. Wien Klin Wochenschr (2014) 0.75
[Recurrent venous thrombosis]. Hamostaseologie (2013) 0.75
[Thrombophilia]. Hamostaseologie (2008) 0.75